Abstract
Introduction: Thyroid cytology is a widely accepted tool in the clinical triaging of nodular lesions. Cell blocks (CBs) can help in the diagnosis of atypical lesions, namely, thyroid Bethesda category of Atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS). Methods: In a series of 224 AUS/FLUS thyroid samples with CB, we studied CB cellularity and feasibility of 3 immunohistochemical markers (cytokeratin 19 [CK19], HBME-1, and galectin-3) apart and in combination. Results: The CBs were non-diagnostic in 34 cases. Twenty-four CBs contained <10 cells, 45 CBs 10–50 cells, and 121 CBs >50 cells. Notably, more cellularity was found in CBs performed by plasma-thrombin and in-house techniques (p < 0.001). The diagnostic accuracy to detect malignancy was 65.1% for CK19, 72.1% for HBME-1, and 70.3% for galectin-3. Conclusion: In conclusion, CB cellularity is essential for successful immunohistochemistry application and further diagnostic workup of AUS/FLUS cases.
References
1.
Kholová
I
, Schalin-Jäntti
C
. Thyroid fine needle aspiration cytology
. In: Huhtaniemi
I
, Martini
L
, editors. Encyclopedia of endocrine diseases
. 2nd ed. Oxford
: Academic Press
; 2018
. p. 565
–72
.2.
Syed
AZ
, Cibas
ES
. The Bethesda system for reporting thyroid cytopathology: definitions, criteria and explanatory notes
. 1st ed. New York, NY, USA
: Springer
; 2010
.3.
Straccia
P
, Rossi
ED
, Bizzarro
T
, Brunelli
C
, Cianfrini
F
, Damiani
D
, et al A meta-analytic review of the Bethesda system for reporting thyroid cytopathology: has the rate of malignancy in indeterminate lesions been underestimated?
Cancer Cytopathol
. 2015 Dec
;123
(12
):713
–22
. .4.
Syed
AZ
, Cibas
ES
. The Bethesda system for reporting thyroid cytopathology: definitions, criteria, and explanatory notes
. 2nd ed. Cham, Switzerland
: Springer
; 2018
.5.
Vuong
HG
, Ngo
HTT
, Bychkov
A
, Jung
CK
, Vu
TH
, Lu
KB
, et al Differences in surgical resection rate and risk of malignancy in thyroid cytopathology practice between Western and Asian countries: a systematic review and meta-analysis
. Cancer Cytopathol
. 2020 Apr
;128
(4
):238
–49
. .6.
Kholova
I
, Ludvikova
M
. Thyroid atypia of undetermined significance or follicular lesion of undetermined significance: an indispensable Bethesda 2010 diagnostic category or waste garbage?
Acta Cytol
. 2014
;58
(4
):319
–29
.7.
Geramizadeh
B
, Bos-Hagh
S
, Maleki
Z
. Cytomorphologic, imaging, molecular findings, and outcome in thyroid follicular lesion of undetermined significance/atypical cell of undetermined significance (AUS/FLUS): a mini-review
. Acta Cytol
. 2019
;63
(1
):1
–9
. .8.
Jain
D
, Mathur
SR
, Iyer
VK
. Cell blocks in cytopathology: a review of preparative methods, utility in diagnosis and role in ancillary studies
. Cytopathology
. 2014 Dec
;25
(6
):356
–71
. .9.
Krogerus
L
, Kholová
I
. Cell block in cytological diagnostics: review of preparatory techniques
. Acta Cytol
. 2018
;62
(4
):237
–43
. .10.
Nambirajan
A
, Jain
D
. Cell blocks in cytopathology: an update
. Cytopathology
. 2018 Dec
;29
(6
):505
–24
. .11.
Shidham
VB
. CellBlockistry: chemistry and art of cell-block making: a detailed review of various historical options with recent advances
. Cytojournal
. 2019
;16
:12
. .12.
Saqi
A
. The state of cell blocks and ancillary testing: past, present, and future
. Arch Pathol Lab Med
. 2016 Dec
;140
(12
):1318
–22
. .13.
da Cunha Santos
G
, Saieg
MA
. Preanalytic specimen triage: smears, cell blocks, cytospin preparations, transport media, and cytobanking
. Cancer
. 2017 Jun
;125
(S6
):455
–64
. .14.
Kholova
I
, Ryska
A
, Ludvikova
M
, Cap
J
, Pecen
L
. Dipeptidyl peptidase IV expression in thyroid cytology: retrospective histologically confirmed study
. Cytopathology
. 2003 Feb
;14
(1
):27
–31
.15.
Cochand-Priollet
B
, Dahan
H
, Laloi-Michelin
M
, Polivka
M
, Saada
M
, Herman
P
, et al Immunocytochemistry with cytokeratin 19 and anti-human mesothelial cell antibody (HBME1) increases the diagnostic accuracy of thyroid fine-needle aspirations: preliminary report of 150 liquid-based fine-needle aspirations with histological control
. Thyroid
. 2011 Oct
;21
(10
):1067
–73
. .16.
Kalfert
D
, Ludvikova
M
, Kholova
I
, Ludvik
J
, Topolocan
O
, Plzak
J
. Combined use of galectin-3 and thyroid peroxidase improves the differential diagnosis of thyroid tumors
. Neoplasma
. 2020 Jan
;67
(1
):164
–70
. .17.
Pusztaszeri
MP
, Sadow
PM
, Faquin
WC
. CD117: a novel ancillary marker for papillary thyroid carcinoma in fine-needle aspiration biopsies
. Cancer Cytopathol
. 2014 Aug
;122
(8
):596
–603
. .18.
Abdou
AG
, Abdelwahed
M
, Said
A
, Taie
DM
, Fahmy
S
. Evaluation of the diagnostic value of Emerin and CD56 in papillary thyroid carcinoma: an immunohistochemical study
. J Immunoassay Immunochem
. 2018
;39
(5
):521
–37
. .19.
Sadowski
SM
, Petrenko
V
, Meyer
P
, Pusztaszeri
M
, Brulhart-Meynet
MC
, Heddad Masson
M
, et al Validation of molecular biomarkers for preoperative diagnostics of human papillary thyroid carcinoma in fine needle aspirates
. Gland Surg
. 2019 Aug
;8
(Suppl 2
):S62
–76
. .20.
Maleki
Z
, Abram
M
, Dell'Aquila
M
, Kilic
I
, Lu
R
, Musarra
T
, et al Insulinoma-associated protein 1 (INSM-1) expression in medullary thyroid carcinoma FNA: a multi-institutional study
. J Am Soc Cytopathol
. 2020 May–Jun
;9
(3
):185
–90
. .21.
Huhtamella
R
, Kholová
I
. Thyroid Bethesda category AUS/FLUS in our microscopes: three-year-experience and cyto-histological correlation
. Cancers
. 2019 Oct 28
;11
(11
):1670
. .22.
Hakso-Makinen
H
, Kholova
I
. New cell block method to enhance the cellular yield in mucous and/or bloody samples
. Acta Cytol
. 2020
;64
(3
):265
–9
.23.
Haugen
BR
. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: what is new and what has changed?
Cancer
. 2017 Feb 1
;123
(3
):372
–81
. .24.
Srebotnik Kirbis
I
, Rodrigues Roque
R
, Bongiovanni
M
, Strojan Flezar
M
, Cochand-Priollet
B
. Immunocytochemistry practices in European cytopathology laboratories-Review of European Federation of Cytology Societies (EFCS) online survey results with best practice recommendations
. Cancer Cytopathol
. 2020 Oct
;128
(10
):757
–66
.25.
Fischer
AH
, Schwartz
MR
, Moriarty
AT
, Wilbur
DC
, Souers
R
, Fatheree
L
, et al Immunohistochemistry practices of cytopathology laboratories: a survey of participants in the College of American Pathologists nongynecologic cytopathology education program
. Arch Pathol Lab Med
. 2014 Sept
;138
(9
):1167
–72
. .26.
Herbert
A
. Cell blocks are not a substitute for cytology: why pathologists should understand cytopathology particularly in their chosen speciality
. Cytopathology
. 2014 Dec
;25
(6
):351
–5
. .27.
Mais
DD
, Crothers
BA
, Davey
DD
, Natale
KE
, Nayar
R
, Souers
RJ
, et al Trends in thyroid fine-needle aspiration cytology practices: results from a College of American Pathologists 2016 practice survey
. Arch Pathol Lab Med
. 2019 Nov
;143
(11
):1364
–72
. .28.
VanderLaan
PA
, Marqusee
E
, Krane
JF
. Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated fna be the preferred initial approach?
Am J Clin Pathol
. 2011 May
;135
(5
):770
–5
. .29.
Cristo
AP
, Goldstein
HF
, Faccin
CS
, Maia
AL
, Graudenz
MS
. Increasing diagnostic effectiveness of thyroid nodule evaluation by implementation of cell block preparation in routine US-FNA analysis
. Arch Endocrinol Metab
. 2016 Aug
;60
(4
):367
–73
. .30.
Abu-Sinna
E
, Hasan
MY
, El-Deftar
MM
, Amer
SA
, Abdelsalam
LO
, Nakhla
JA
. Galectin-3 and HBME-1 expression on agarose cell blocks from fine-needle aspirates of follicular cell-derived thyroid tumors
. J Cytol
. 2018 Jan–Mar
;35
(1
):27
–32
. .31.
Desai
KM
, Angadi
PV
, Kale
AD
, Hallikerimath
S
. Assessment of cell block technique in head and neck pathology diagnoses: a preliminary study
. Diagn Cytopathol
. 2019 May
;47
(5
):445
–51
. .32.
de Matos
LL
, Del Giglio
AB
, Matsubayashi
CO
, de Lima Farah
M
, Del Giglio
A
, da Silva Pinhal
MA
. Expression of CK-19, galectin-3 and HBME-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis
. Diagn Pathol
. 2012 Aug 13
;7
:97
. .33.
Ratour
J
, Polivka
M
, Dahan
H
, Hamzi
L
, Kania
R
, Dumuis
ML
, et al Diagnosis of follicular lesions of undetermined significance in fine-needle aspirations of thyroid nodules
. J Thyroid Res
. 2013
;2013
:250347
. .34.
Fadda
G
, Rossi
ED
, Raffaelli
M
, Pontecorvi
A
, Sioletic
S
, Morassi
F
, et al Follicular thyroid neoplasms can be classified as low- and high-risk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology
. Eur J Endocrinol
. 2011 Sept
;165
(3
):447
–53
. .35.
Margari
N
, Giovannopoulos
I
, Pouliakis
A
, Mastorakis
E
, Gouloumi
AR
, Panayiotides
IG
, et al Application of immunocytochemistry on cell block sections for the investigation of thyroid lesions
. Acta Cytol
. 2018
;62
(2
):137
–44
. .36.
Rossi
ED
, Fadda
G
, Schmitt
F
. The nightmare of indeterminate follicular proliferations: when liquid-based cytology and ancillary techniques are not a moon landing but a realistic plan
. Acta Cytol
. 2014
;58
(6
):543
–51
. .37.
Cochand-Priollet
B
, Schmitt
FC
, Totsch
M
, Vielh
P
; European Federation of Cytology Societies’ Scientific C
. The Bethesda terminology for reporting thyroid cytopathology: from theory to practice in Europe
. Acta Cytol
. 2011
;55
(6
):507
–11
.38.
Satturwar
S
, Malenie
R
, Sutton
A
, Dai
D
, Aly
FZ
. Validation of immunohistochemical tests performed on cytology cell block material: practical application of the College of American Pathologists’ guidelines
. Cytojournal
. 2019
;16
:6
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
